GSK Says Tests Show Vir Antibody Drug Works Against Omicron

GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with U.S. partner Vir has indicated that the drug also works against the new Omicron variant. Read More